ロード中...

Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial

BACKGROUND: Several countries have implemented a 2-dose (2D) human papillomavirus (HPV) vaccination schedule for adolescents based on immunobridging studies. We compared immunogenicity of 2D vs 3-dose (3D) schedules of the quadrivalent vaccine (4vHPV) up to 10 years after the first dose. METHODS: Gi...

詳細記述

保存先:
書誌詳細
出版年:Clin Infect Dis
主要な著者: Donken, Robine, Dobson, Simon R M, Marty, Kim D, Cook, Darrel, Sauvageau, Chantal, Gilca, Vladimir, Dionne, Marc, McNeil, Shelly, Krajden, Mel, Money, Deborah, Kellner, James, Scheifele, David W, Kollmann, Tobias, Bettinger, Julie A, Liu, Shuzhen, Singer, Joel, Naus, Monika, Sadarangani, Manish, Ogilvie, Gina S
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7428395/
https://ncbi.nlm.nih.gov/pubmed/31617568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz887
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!